Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Grant revenue	$ 0	$ 0	$ 0	$ 81,526
Operating expenses:
Research and development	4,719,728	1,307,177	7,538,917	2,637,721
General and administrative	1,459,093	935,311	2,910,518	2,114,335
Total operating expenses	6,178,821	2,242,488	10,449,435	4,752,056
Loss from operations	(6,178,821)	(2,242,488)	(10,449,435)	(4,670,530)
Other income:
Interest income	251,201	789	483,899	1,316
Net loss	$ (5,927,620)	$ (2,241,699)	$ (9,965,536)	$ (4,669,214)
Basic and diluted:
Net loss per common share (in dollars per share)	$ (0.22)	$ (0.18)	$ (0.38)	$ (0.47)
Weighted average shares outstanding (in shares)	26,443,649	12,721,696	26,391,403	9,931,088